CLBT
+0.0 · +0.00%
USD · NASDAQ

Cellebrite DI(CLBT) Stock Analysis | Technology

USD --+0.00%
Reward67High
Risk29Low
75%Data
Revenue growing 16% YoY
Quality Compounder
Market Cap:2.77Bn
ⓘ
Reward Rating
67
High
Reward Assessment
75% data coverage
Top 25% of stocksView factors
ⓘ
Risk Rating
29
Low
Risk Assessment

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on CLBT to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
New listing — limited trading history
Fundamental and analyst data are available for CLBT, but momentum and volatility metrics will develop as more trading history accumulates (0 trading sessions so far).
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $15.36.

What is Cellebrite DI?

develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.

CLBT · Verdict

Solid reward · low risk

CLBT scores well on cash flow and balance sheet with no major weaknesses flagged in the model.

Based on 88% data coverage

CLBT · Verdict

What’s working & what to watch

Strengths 4

  • Cash flow94/100

    33% free-cash-flow margin

  • Balance sheet93/100

    Interest covered 174.4×

  • Growth77/100

    Rev +20.7% CAGR · earnings -13.4%

  • Profitability75/100

    16% net margin · 12% ROE

No major weaknesses flagged.

Model-based scoring. For information only — not financial advice.

What is Cellebrite DI?

develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. The company is listed on the NASDAQ in USA, operating in the Technology sector, with a market capitalisation of 2.77B, and a P/E ratio of 48.0x.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Strong margins and consistent earnings support financial stability.
Risk
Below-average volatility supports a steadier risk profile.
Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: High (67)

The scoring profile indicates moderate reward potential, with growth and profitability as the leading contributors. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Similar stocks to compare

A short list of Software - Infrastructure names that are close enough in size to make side-by-side comparison useful.

Company Information
SectorTechnology
IndustrySoftware - Infrastructure
Market Cap2.77B
P/E Ratio48.0435
Dividend YieldN/A
Beta1.176
Insider Activity
12M windowNo data
No insider activity data available for this ticker.